Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats HIV-1 infection. NDA 22417, held by Abbvie. Ritonavir.
As of Nov 14, 2026, NDA 22417 (Norvir), held by Abbvie, was first approved by FDA on Feb 10, 2010, with 20 approved supplements and 0 published complete response letters.
First approved: Feb 10, 2010
Review: Standard
Supplements approved: 20
Complete response letters: 0
What It's For
From the FDA-approved label (Indications and Usage)
NORVIR tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters.Drugs@FDA and FDA complete response letters
